Navigation Links
Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
Date:9/10/2007

ndicates the improvement in DAS-28 compared to placebo was statistically significant in the 800 mg dose group at 12 weeks and at all subsequent assessments, and in the 1600 mg dose group at 16 weeks and at all subsequent assessments. At 24 weeks, ACR 20, 50 and 70 response rates in the 800 mg dose group were 65 percent, 26 percent and 0 percent, respectively. ACR 20, 50 and 70 response rates in the 1600 mg dose group were 61 percent, 13 percent and 4 percent, respectively. ACR 20, 50 and 70 response rates at 24 weeks in the placebo group were 33 percent, 9 percent and 2 percent, respectively.

TRU-015 administered as a single dose was generally well tolerated, and only one subject in the 400 mg group experienced a grade 3 adverse event on the day of infusion.

"We are pleased that the positive results of this study confirm the activity seen in our prior study and demonstrate that TRU-015 can meaningfully improve disease activity in patients with RA," said Peter Thompson, M.D., FACP, president, chief executive officer and chairman of Trubion. "We are working with our partner to define the most effective development strategy for TRU-015 in RA that minimizes time-to-market while maximizing our competitive differentiation. We currently believe this will include additional clinical study before commencement of a Phase III trial."

Conference Call Details

Trubion will host a conference call and webcast to discuss its preliminary analysis of the Phase IIb results with TRU-015 for RA. The call will be held today at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. The live event will be available from Trubion's Web site at http://investors.trubion.com/events.cfm, or by calling (800) 289-0494 or (913) 981-5520. A replay of the discussion will be available beginning later today from Trubion's Web site or by calling (888) 203-1112 or (719) 457-0820, and entering 5763754. The telephone replay
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... ATLANTA, Dec. 16 Medlytix, a national ... reaching a key half-billion dollar milestone - the ... have provided in financial assistance to more than ... job of properly classifying charity care - in ... each of these hospitals enhanced their bottom lines ...
(Date:12/16/2009)... CLEVELAND, Dec. 16 DATATRAK International, ... company focused on global eClinical solutions for ... release of its version 9.0 eClinical Software. ... vision for product and service delivery and ... ONE,s Knowledge(TM) offering: the DATATRAK Learning Center(TM) ...
(Date:12/16/2009)... 16 AVAX Technologies, Inc. (Pink Sheets: ... it recently closed a bridge loan financing (the ... Warrant Purchase Agreement (the "Agreement") with Firebird Global ... the Company sold a convertible promissory note, due ... of US$1,400,000, and issued a warrant to purchase ...
Breaking Medicine Technology:Healthcare Scoring System Allows Hospitals To Increase Charity Care 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 4DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4Noted Vertebroplasty Expert Cites Concerns About Recently Published Study 54266 1Noted Vertebroplasty Expert Cites Concerns About Recently Published Study 54266 2Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 1Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 2Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 3Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 4Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 5Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 6Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 7Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 8Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors 54259 1Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors 54259 2
(Date:12/17/2009)... ( www.CareTech.com ), an information technology (IT) and web ... was named Best in KLAS, Extensive IT Outsourcing ... in KLAS Awards: Software & Professional Services report. ... in key market segments including EMRs, cardiology systems, IT ... performance score was 90.3 on a 100-point scale and ...
(Date:12/17/2009)... M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null genotypes ... The results regarding the association between GSTM1 and GSTT1 ... were contradictory. However, the majority of previous reports are ... of the GSTM1/GSTT1 null genotype with the risk of ... with larger numbers of samples. , A research ...
(Date:12/17/2009)... in Copenhagen approaches its conclusion, negotiations are focusing ... change. The new ,Reducing Emissions from Deforestation and ... a central element of any new agreement. , ... greenhouse gas emissions, this new policy would enable ... emissions reduction. Linked to this, developed countries are ...
(Date:12/17/2009)... differences that explain the aging inequity , , ... discovered yet another gender inequity: Women develop more ... age than men do. , The disadvantage had ... "irrefutable scientific evidence," said Dr. Foad Nahai, a ... the Aesthetic Surgery Journal . The study ...
(Date:12/17/2009)... Efficient Mechanism to Pursue Approval in Multiple ... /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... initiated the regulatory approval process for its ... Decentralized Procedure (DCP). The DCP provides an ... simultaneously pursue regulatory approval for a medicinal ...
Breaking Medicine News(10 mins):Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 2Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 3Health News:Forests take center stage at Copenhagen 2Health News:Mouth Area Wrinkles More in Women Than Men 2Health News:Mouth Area Wrinkles More in Women Than Men 3Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 2Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 3
... in seven Americans over the age of 70 suffers from ... to include men and women from all regions of the ... the population age 71 and older, have some form of ... increased dramatically with age, from five percent of those aged ...
... 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) ... of the Company, will present at the CIBC ... City on Monday, November 5, 2007 at 3:40,p.m. ... webcast for this presentation by,visiting the "Events" section ...
... Homes in California will simultaneously open their doors ... invited to cover the,festivities, CENTRAL COAST, Calif., Oct. ... a nursing home. Nurse administrators,don,t often see miniature witches ... 90-year-old soldiers or 80-year-young,ballerinas! But at more than 150 ...
... in California will simultaneously open their doors Wednesday ... to cover the,festivities, INLAND EMPIRE, Calif., Oct. 30 ... nursing home. Nurse administrators,don,t often see miniature witches and ... soldiers or 80-year-young,ballerinas! But at more than 150 nursing ...
... Nursing Homes in California will simultaneously open their doors ... are invited to cover the,festivities, REDDING, Calif., Oct. ... a nursing home. Nurse administrators don,t often,see miniature witches ... 90-year-old soldiers or 80-year-young ballerinas! But at more,than 150 ...
... simultaneously open their doors,Wednesday to Trick or Treaters and ... Calif., Oct. 30 It,s not every day,pirates and ... miniature witches and 3-foot tall bumblebees, and little goblins ... at more,than 150 nursing homes in California this Halloween, ...
Other Medicine News:Health News:1 in 7 Americans over age 70 has dementia 2Health News:1 in 7 Americans over age 70 has dementia 3Health News:1 in 7 Americans over age 70 has dementia 4Health News:Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference 2Health News:Halloween Events on California's Central Coast Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Southern California Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Redding, Calif., Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Eureka, California Bring Young and Old Together for a Ghoulish Good Time 2
0.5 mm short 120 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
The popular Bechert nucleus rotator has been modified to have the shaft angled 10 mm from tip to bend for ease of manipulation of the lens nucleus in the anterior chamber. Round knurled handle....
... Multi-purpose manipulator with broad tip ... the nucleus during phacoemulsification. The ... through the side port incision ... to guide the lens down ...
1.0 mm long 90 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
Medicine Products: